Tris trial is registered with FDA with number: NCT01315496. The sponsor of the trial is Green Cross Corporation and it is looking for 214 volunteers for the current phase.
Official trial title:
A Placebo-controlled, Randomized, Double-blind, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Administration of 'IV-Globulin S Inj.' in Adult Subjects With Community-Acquired Severe Sepsis or Septic Shock